UV-B light sensing mechanism discovered in plant roots

December 08, 2008

Scientists have discovered that plant roots can sense UV-B light and have identified a specific gene that is a vital player in UV-B signaling, the communication between cells.

A study published Dec. 8 in the Early Edition of PNAS reveals that the gene RUS1 measures UV-B light levels and passes this information on to other parts of the plant responsible for growth and development. A low dosage of UV-B light, for example the levels found in shady conditions or under fluorescent lighting, can provide important signals to the rest of the plant and is therefore beneficial to normal plant growth. It helps young plants stay on the right track of development and aids seedling morphogenesis, but too much UV-B light can be toxic.

The study found that plants with a mutated UV-B light sensor gene become hypersensitive to UV-B light and even under low intensity levels of UV-B light, their root growth is stunted and they fail to grow leaves. Therefore the RUS1 gene is responsible for ensuring that young seedlings develop normally even when their roots are exposed to UV-B light.

It's unusual that roots, normally covered in soil, should have sensors for UV-B light, but the RUS1 gene is crucial at the young seedling stage when a plant's roots are resting on the soil surface. Later in a plant's life, roots can be exposed after rainwash, geological movements or animal activity.

The discovery of RUS1 provides scientists with a platform to examine other key genes that receive UV-B light and translate light information into how the plant should develop.
-end-
The paper's corresponding author is Zheng-Hui He, professor of biology at San Francisco State University. In addition to He, co-authors include SF State researchers Hongyun Tong, Colin D. Leasure, Xuewen Hou, Gigi Yuen, and Winslow Briggs from the Carnegie Institute of Washington.

San Francisco State University

Related Gene Articles from Brightsurf:

NIH gene therapy startup to increase AAV gene therapy efficiency
Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH).

Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help
MIT researchers find that astrocytes with the risk-increasing APOE4 variant show deficits of key cellular function called endocytosis, but overexpressing another Alzheimer's associated gene, PICALM, overcame the defect

New Human Gene Therapy editorial: Concern following gene therapy adverse events
Response to the recent report of the deaths of two children receiving high doses of a gene therapy vector (AAV8) in a Phase I trial for X-linked myotubular myopathy (MTM).

Gene therapy/gene editing combo could offer hope for some genetic disorders
A hybrid approach that combines elements of gene therapy with gene editing converted an experimental model of a rare genetic disease into a milder form, significantly enhancing survival, shows a multi-institutional study led by the University of Pennsylvania and Children's National Hospital in Washington, D.C.

Unraveling gene expression
EPFL chemists have uncovered the first steps in the process of gene expression by showing how the protein Rap1 pries open the tightly wound, compacted structure of DNA in the cell to gain access to specific genes.

Gene coding error found in rare, inherited gene cof lung-scarring disorder linked to short telomeres
By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person's relatives, Johns Hopkins Medicine researchers say they have found a coding error in a single gene that is likely responsible for a rare form of the disease and the abnormally short protective DNA caps on chromosomes long associated with it.

The two faces of the Jekyll gene
Genes which are specific to a species or group of species can reflect important genetic changes within lineages.

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.

Blindness gene discovered
Researchers from UNIGE have investigated a recessive genetic disorder that destroys the eyes from developing and results in childhood blindness.

Gene editing just got easier
An international team of researchers has made CRISPR technology more accessible and standardized by simplifying its complex implementation in a way that offers a broad platform for off-the shelf genome engineering.

Read More: Gene News and Gene Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.